Newswise — COLUMBUS, Ohio – A high-fat diet triggers chemical reactions in female mice that could explain why women are more likely than men to gain fat in the abdomen after eating excess saturated fat, new research suggests. The study also sheds light on why women gain fat following menopause.
Scientists identified events in female mice that start with the activation of an enzyme and end with the formation of visceral fat – fat that accumulates around internal organs and is linked to a higher risk for Type 2 diabetes, heart disease and cancer.
At least one function for this enzyme is the production of a powerful hormone, which then drives up the formation of visceral fat cells. The source of this hormone is vitamin A.
This enzyme appears to be activated at higher levels in females than in males when both sexes eat a high-fat diet. When researchers genetically altered mice by deleting the enzyme, female mice stayed lean, especially in the abdominal area, even when they continued to eat a lot of fat. Males without the enzyme also developed less fat, but the effect was far less significant than in females.
The results suggest the enzyme could be a target for sex-specific anti-obesity therapy.
(See related news release at http://researchnews.osu.edu/archive/fatcapsule.htm)
“If you asked most people what they believe causes obesity, they would probably say high food consumption and a sedentary lifestyle. But we see that there are genetic factors telling the body what to do with fat,” said Ouliana Ziouzenkova, assistant professor of human nutrition at Ohio State University and senior author of the study. “A high-fat diet acts on our genetics to make us more fat or less fat. The diet is not powerful enough to do this on its own.”
Further experiments showed that fat cells in female mice lacking the enzyme could produce proteins that use fat for heat, meaning the fat in females was burned away.
Researchers also studied fat tissue from human surgery patients and found the same enzyme was present in human tissue, and its levels were markedly higher in cells extracted from the visceral fat tissue of obese women compared to cells from lean women.
Finally, the study suggested that estrogen suppresses the enzyme’s activity, which might help explain why postmenopausal women with decreased estrogen in their bodies tend to accumulate fat in their bellies.
The research is published online in the journal Diabetes.
The hormonal effect seen in these mice relates at least in part to how the female body processes vitamin A, a nutrient that is converted into a variety of compounds. These include a molecule that supports the burning of fat for energy, as well as retinoic acid, the hormone in this study that leads to the formation of visceral fat. The scientists showed that a high-fat diet functions as a switching mechanism that breaks down the fat-burning molecule and leads to activation of the enzyme and production of retinoic acid, ending in the development of visceral fat.
A year ago, Ziouzenkova’s lab identified the one of these enzymes that relates to fat accumulation: Aldehyde Dehydrogenase 1, or Aldh1a1. In the current study, she and colleagues conducted numerous experiments in mice to track the events that followed activation of this enzyme.
The researchers compared normal mice with genetically altered mice lacking the enzyme over almost a year of eating a high-fat diet. Male and female normal mice gained weight on the high-fat diet, as expected, though the females developed more visceral fat that surrounds the organs than did males, a trend also seen in humans as the result of eating excess fat. (In contrast, on a regular diet, men are more likely than women to form abdominal fat.) Both sexes of mice developed peripheral subcutaneous fat, which lies just under the skin and has some benefits.
In mice without the enzyme, however, the males developed some fat but females remained lean, and this occurred even when females ate more food than males. The researchers determined that without Aldh1a1, the females were not producing retinoic acid, and that protected them from producing visceral fat. Meanwhile, males retained the ability to produce retinoic acid.
The scientists then analyzed the proteins contained in fat tissue in male and female mice lacking the enzyme, and saw that only the females’ fat cells contained high levels of a protein that releases fat from fat cells to support fat burning. This release led to production of another protein that converts fat to heat, essentially burning the fat, in the form of lipids, away.
“Without production of the hormone retinoic acid, females are burning fat and expending the energy in the form of heat. That’s why they stay very lean,” Ziouzenkova said. “And this process was specifically affecting visceral fat.”
The researchers surgically removed the ovaries of mice to test whether estrogen could be related to visceral fat production in females. As soon as the animals became menopausal and weren’t producing estrogen, they began to produce retinoic acid, which led to visceral fat formation.
“Estrogen was sufficient to protect female mice from both hormonal and, partially, diet-induced obesity. This means estrogen is suppressing activation of the obesity-inducing hormone, and as soon as we lose this estrogen during menopause, the visceral fat starts to grow,” said Ziouzenkova, also an investigator in Ohio State’s Comprehensive Cancer Center.
Using another mouse model that allowed researchers to measure hormone production specifically, the researchers observed that female mice on a regular diet barely produced retinoic acid. However, females on a high-fat diet produced high levels of the hormone and, in turn, showed a nine-fold increase in visceral fat compared to visceral fat developed by males on a high-fat diet. This was the final determinant that the high-fat diet triggers this cascade of events ending in visceral fat formation.
Because the human fat tissue samples the researchers analyzed also showed elevated levels of Aldh1a1 in cells extracted from tissue in obese women, “it could be that what we show about this hormone’s importance to visceral obesity in mice is also true for humans,” Ziouzenkova said.
“As soon as a female starts the high-fat diet consumption, a mechanism for hormonal regulation is turned on and she starts to produce retinoic acid and her metabolism becomes super thrifty. Females will store more fat than they burn,” she said. “By removing the Aldh1a1 enzyme in visceral fat, we could make females release fat and burn it. We make them super-metabolically active instead.”
The study identifies this enzyme as a potential sex-specific therapy for obesity, but only in very targeted ways. Deleting the enzyme genetically would be damaging because Aldh1a1 is present in all cells, meaning it has additional functions. Ziouzenkova is investigating ways to target delivery of enzyme-free cells directly to fat as a potential obesity remedy.
This work is supported by a Pilot Industry Partnership grant to Ohio State’s Center for Clinical and Translational Science (supported by the National Center for Research Resources), the National Institutes of Health, a College of Education and Human Ecology Seed Grant, a Food Innovation Center Seed Grant, an Ohio State International Office Seed Grant, an Alpha Omega Alpha Honor Medical Society 2011 Carolyn L. Kuckein Student Research Fellowship, an OSU Comprehensive Cancer Center Support Grant, a National Research Service Award grant and an EHE Dissertation fellowship.
Graduate student Rumana Yasmeen, medical student Barbara Reichert and postdoctoral researcher Jeffrey Deiuliis led much of this work. Additional co-authors include Fangping Yang, Alisha Lynch, Joseph Meyers and Katharina Volz of the Department of Human Nutrition; and Sanjay Rajagopalan of the Davis Heart and Lung Research Institute; Sangsu Shin and Kichoon Lee of the Department of Animal Sciences; Kari Green of the Mass Spectrometry and Proteomics Facility; Hansjuerg Alder of the Comprehensive Cancer Center Nucleic Acid Shared Resource, all at Ohio State; Molly Sharlach of the University of California, Berkeley; Gregg Duester of the Sanford-Burnham Medical Research Institute in La Jolla, Calif.; and Rudolf Zechner of Karl Franzens University in Graz, Austria.